As mRNA technology has been thrust into the mainstream with the advent of COVID-19 vaccines, the US Food and Drug Administration (FDA) has begun training new investigators to meet the increasing demand for mRNA vaccine manufacturing inspections. The trainees will undergo a mix of in-person, virtual reality, and augmented reality training modules. This expansion comes in response to new mRNA treatment programs expected to emerge in the coming years.
According to Josh Sullivan of Endpoints News, “BioNTech, Pfizer’s partner in its Covid-19 vaccine efforts, recently revealed that it is paying Matinas BioPharma to gain exclusive access to its lipid nanocrystal drug delivery platform for the oral delivery of mRNA. It also was one of the first companies to announce plans for the massive mRNA manufacturing sites that are being built. BioNTech plans to piggyback off the success of the technology by pivoting to work on malaria vaccines once the Covid-19 pandemic has subsided.”
Read more by clicking here.
(Source: Endpoints News, May 5th, 2022)